10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 322 filers reported holding 10X GENOMICS INC in Q1 2021. The put-call ratio across all filers is 1.39 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $979,316 | -23.1% | 23,741 | +4.2% | 0.00% | 0.0% |
| Q2 2023 | $1,272,761 | -2.0% | 22,793 | -2.1% | 0.00% | 0.0% |
| Q1 2023 | $1,298,959 | +38.8% | 23,283 | -9.4% | 0.00% | 0.0% |
| Q4 2022 | $936,143 | +53.0% | 25,690 | +19.6% | 0.00% | – |
| Q3 2022 | $612,000 | -40.5% | 21,479 | -5.5% | 0.00% | -100.0% |
| Q2 2022 | $1,028,000 | -34.4% | 22,728 | +10.2% | 0.00% | 0.0% |
| Q1 2022 | $1,568,000 | -51.8% | 20,625 | -5.6% | 0.00% | -50.0% |
| Q4 2021 | $3,255,000 | -19.6% | 21,850 | -21.5% | 0.00% | -33.3% |
| Q3 2021 | $4,051,000 | -33.2% | 27,831 | -10.2% | 0.00% | -25.0% |
| Q2 2021 | $6,067,000 | +44.2% | 30,979 | +33.3% | 0.00% | +33.3% |
| Q1 2021 | $4,208,000 | +35.5% | 23,248 | +6.0% | 0.00% | +50.0% |
| Q4 2020 | $3,105,000 | +113.0% | 21,928 | +87.5% | 0.00% | +100.0% |
| Q3 2020 | $1,458,000 | +28.0% | 11,697 | -8.3% | 0.00% | 0.0% |
| Q2 2020 | $1,139,000 | – | 12,755 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |